BackMirati Therapeutics Overview

Mirati Therapeutics Operating Income

Operating Income for MRTX.

Quarterly Operating Income

$-172054000.00
↓ 7.72% YoY

As of Sep 30, 2023

Annual Operating Income (TTM)

$-764870000.00
↑ 2.68% YoY

Trailing 12 months ending Sep 30, 2023

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin